These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 12486847
1. Chemical and physical labyrinthectomy for Meniere's disease. Berryhill WE, Graham MD. Otolaryngol Clin North Am; 2002 Jun; 35(3):675-82. PubMed ID: 12486847 [Abstract] [Full Text] [Related]
2. Chemical perfusion of the inner ear. Jackson LE, Silverstein H. Otolaryngol Clin North Am; 2002 Jun; 35(3):639-53. PubMed ID: 12486845 [Abstract] [Full Text] [Related]
3. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss. Derebery MJ, Fisher LM, Berliner K, Chung J, Green K. Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498 [Abstract] [Full Text] [Related]
4. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Minor LB. Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525 [Abstract] [Full Text] [Related]
5. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection. Quaranta A, Aloisi A, De Benedittis G, Scaringi A. Ann N Y Acad Sci; 1999 Nov 28; 884():410-24. PubMed ID: 10842610 [Abstract] [Full Text] [Related]
6. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease. Perez N, Boleas MS, Martin E. Audiol Neurootol; 2005 Nov 28; 10(2):69-78. PubMed ID: 15650298 [Abstract] [Full Text] [Related]
7. Intratympanic gentamicin for intractable Meniere's disease. Perez N, Martín E, García-Tapia R. Laryngoscope; 2003 Mar 28; 113(3):456-64. PubMed ID: 12616197 [Abstract] [Full Text] [Related]
8. Histopathology of the vestibular end organs after intratympanic gentamicin failure for Meniere's disease. Ishiyama G, Lopez I, Baloh RW, Ishiyama A. Acta Otolaryngol; 2007 Jan 28; 127(1):34-40. PubMed ID: 17364327 [Abstract] [Full Text] [Related]
9. Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results. Driscoll CL, Kasperbauer JL, Facer GW, Harner SG, Beatty CW. Laryngoscope; 1997 Jan 28; 107(1):83-9. PubMed ID: 9001270 [Abstract] [Full Text] [Related]
10. Long-term vertigo control in patients after intratympanic gentamicin instillation for Ménière's disease. Bodmer D, Morong S, Stewart C, Alexander A, Chen JM, Nedzelski JM. Otol Neurotol; 2007 Dec 28; 28(8):1140-4. PubMed ID: 18084826 [Abstract] [Full Text] [Related]
12. Intratympanic gentamicin treatment for Ménière's disease: a randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study. Bremer HG, van Rooy I, Pullens B, Colijn C, Stegeman I, van der Zaag-Loonen HJ, van Benthem PP, Klis SF, Grolman W, Bruintjes TD. Trials; 2014 Aug 18; 15():328. PubMed ID: 25135244 [Abstract] [Full Text] [Related]
13. Hearing loss following intratympanic instillation of gentamicin for the treatment of unilateral Meniere's disease. Kaplan DM, Nedzelski JM, Al-Abidi A, Chen JM, Shipp DB. J Otolaryngol; 2002 Apr 18; 31(2):106-11. PubMed ID: 12019738 [Abstract] [Full Text] [Related]
14. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy. Crane BT, Minor LB, Della Santina CC, Carey JP. Otol Neurotol; 2009 Aug 18; 30(5):619-24. PubMed ID: 19503016 [Abstract] [Full Text] [Related]